GPR141 and hepatocellular carcinoma: To address this knowledge gap, we performed immunohistochemical analysis using clinically obtained lung adenocarcinoma (LUAD) and hepatocellular carcinoma (HCC) samples to comparatively evaluate GPR141 expression patterns between normal and tumor tissues.